B-cell lymphoma/leukemia 10 promotes oral cancer progression through STAT1/ATF4/S100P signaling pathway. Oncogene. 2015;34(10): 1207-19.Wu TS, Tan CT, Chang CC, Lin BR, Lai WT, Chen ST, Yen‑Ping Kuo M, Rau CL, Jaw FS and Chang HH: B‑cell lymphoma/...
B. Addiction to oncogenes — the Achilles heal of cancer. Science 297, 63–64 (2002). Article CAS PubMed Google Scholar Davis, R. E. et al. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463, 88–92 (2010). Article PubMed PubMed Central CAS ...
Cutaneous B-Cell Lymphoma Non-Hodgkin Lymphoma (NHL) News & Perspective COVID Vaccine–Induced T-Cell Responses Help Compensate for B-Cell Deficiency NICE Approves CAR T-Cell Therapy for Patients With Lymphoma Mantle Cell Lymphoma: Drug Combo Improves PFS Diffuse Large B-Cell Lymphoma Highl...
In April 2021, loncastuximab tesirine was granted approval by the FDA for use in patients with relapsed or refractory large B-cell lymphoma following 2 or more lines of systemic therapy, including DLBCL not otherwise specified, DLBCL arising from low-grade lymphoma, and high-grade B-cell l...
B-cell lymphoproliferative disorders Lymphoplasmacytic lymphoma is a neoplasm of small B-lymphocytes, plasmacytoid lymphocytes, and plasma cells in the lymph nodes and bone marrow [2]. The patients usually have a monoclonal serum protein with hyperviscosity or with cryoglobulinemia [3]. The plasmacyt...
What type of cancer is B-cell lymphoma?Term for B-cell lymphomaB-cell lymphoma is a type of non-solid tumor known as blood cancer. Blood cancers are further divided into leukemia and lymphoma. Because B-cells are derived from lymph nodes they are termed a type of lymphoma....
Over-expression of MYC leads to an increased replication activity and is associated with different types of cancer. This holds also true for tumors of the immune system especially aggressive B-cell non-Hodgkin lymphomas (B-NHL) such as Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (...
[2]Roschewski M, Phelan JD, Wilson WH. Molecular classification and treatment of diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma[J]. Cancer J, 2020, 26(3): 195-205. DOI: 10.1097/PPO.00000...
Chimeric antigen receptor (CAR) T cells used for the treatment of B cell malignancies can identify T cell subsets with superior clinical activity. Here, using infusion products of individuals with large B cell lymphoma, we integrated functional profiling using timelapse imaging microscopy in nanowell...
et al. Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era. Cancer Sci 100, 1842–1847 (2009). 32. Bai, M. et al. B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas. Anticancer Res 25, 347–362 (2005)...